Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8527492rdf:typepubmed:Citationlld:pubmed
pubmed-article:8527492lifeskim:mentionsumls-concept:C0205282lld:lifeskim
pubmed-article:8527492lifeskim:mentionsumls-concept:C0032405lld:lifeskim
pubmed-article:8527492lifeskim:mentionsumls-concept:C0031437lld:lifeskim
pubmed-article:8527492lifeskim:mentionsumls-concept:C0023688lld:lifeskim
pubmed-article:8527492lifeskim:mentionsumls-concept:C1167622lld:lifeskim
pubmed-article:8527492lifeskim:mentionsumls-concept:C0379037lld:lifeskim
pubmed-article:8527492pubmed:issue5lld:pubmed
pubmed-article:8527492pubmed:dateCreated1996-1-29lld:pubmed
pubmed-article:8527492pubmed:abstractTextA non-covalently binding inhibitory ligand of poly(ADP-ribose) polymerase, 5-iodo-6-amino-1,2-benzopyrone, when incubated at 5-600 microM external concentration with an E-ras-transformed tumorigenic cell line or with human prostatic carcinoma cells for 40 to 60 days converts both cancer cells to a non-tumorigenic phenotype that is characterized by drastic changes in cell morphology, absence of tumorigenicity in nude mice, and a high rate of aerobic glycolysis.lld:pubmed
pubmed-article:8527492pubmed:languageenglld:pubmed
pubmed-article:8527492pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8527492pubmed:citationSubsetIMlld:pubmed
pubmed-article:8527492pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8527492pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8527492pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8527492pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8527492pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8527492pubmed:statusMEDLINElld:pubmed
pubmed-article:8527492pubmed:issn0300-9084lld:pubmed
pubmed-article:8527492pubmed:authorpubmed-author:KunEElld:pubmed
pubmed-article:8527492pubmed:authorpubmed-author:BauerP IPIlld:pubmed
pubmed-article:8527492pubmed:authorpubmed-author:YoungL JLJlld:pubmed
pubmed-article:8527492pubmed:authorpubmed-author:HakamAAlld:pubmed
pubmed-article:8527492pubmed:authorpubmed-author:KirstenEElld:pubmed
pubmed-article:8527492pubmed:authorpubmed-author:VaradiGGlld:pubmed
pubmed-article:8527492pubmed:authorpubmed-author:ComstockJ AJAlld:pubmed
pubmed-article:8527492pubmed:issnTypePrintlld:pubmed
pubmed-article:8527492pubmed:volume77lld:pubmed
pubmed-article:8527492pubmed:ownerNLMlld:pubmed
pubmed-article:8527492pubmed:authorsCompleteYlld:pubmed
pubmed-article:8527492pubmed:pagination374-7lld:pubmed
pubmed-article:8527492pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8527492pubmed:meshHeadingpubmed-meshheading:8527492-...lld:pubmed
pubmed-article:8527492pubmed:meshHeadingpubmed-meshheading:8527492-...lld:pubmed
pubmed-article:8527492pubmed:meshHeadingpubmed-meshheading:8527492-...lld:pubmed
pubmed-article:8527492pubmed:meshHeadingpubmed-meshheading:8527492-...lld:pubmed
pubmed-article:8527492pubmed:meshHeadingpubmed-meshheading:8527492-...lld:pubmed
pubmed-article:8527492pubmed:meshHeadingpubmed-meshheading:8527492-...lld:pubmed
pubmed-article:8527492pubmed:meshHeadingpubmed-meshheading:8527492-...lld:pubmed
pubmed-article:8527492pubmed:meshHeadingpubmed-meshheading:8527492-...lld:pubmed
pubmed-article:8527492pubmed:meshHeadingpubmed-meshheading:8527492-...lld:pubmed
pubmed-article:8527492pubmed:meshHeadingpubmed-meshheading:8527492-...lld:pubmed
pubmed-article:8527492pubmed:meshHeadingpubmed-meshheading:8527492-...lld:pubmed
pubmed-article:8527492pubmed:meshHeadingpubmed-meshheading:8527492-...lld:pubmed
pubmed-article:8527492pubmed:meshHeadingpubmed-meshheading:8527492-...lld:pubmed
pubmed-article:8527492pubmed:meshHeadingpubmed-meshheading:8527492-...lld:pubmed
pubmed-article:8527492pubmed:meshHeadingpubmed-meshheading:8527492-...lld:pubmed
pubmed-article:8527492pubmed:meshHeadingpubmed-meshheading:8527492-...lld:pubmed
pubmed-article:8527492pubmed:meshHeadingpubmed-meshheading:8527492-...lld:pubmed
pubmed-article:8527492pubmed:meshHeadingpubmed-meshheading:8527492-...lld:pubmed
pubmed-article:8527492pubmed:meshHeadingpubmed-meshheading:8527492-...lld:pubmed
pubmed-article:8527492pubmed:year1995lld:pubmed
pubmed-article:8527492pubmed:articleTitleReversion of malignant phenotype by 5-iodo-6-amino-1,2-benzopyrone a non-covalently binding ligand of poly(ADP-ribose) polymerase.lld:pubmed
pubmed-article:8527492pubmed:affiliationLaboratory for Environmental Toxicology and Chemistry, San Francisco State University, Tiburon, CA 94920, USA.lld:pubmed
pubmed-article:8527492pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8527492pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
pubmed-article:8527492pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8527492lld:pubmed